ProSomnus Sleep Technologies is the Leader in Precision Oral Appliance Therapy for OSA San Francisco, CA, May 21, 2018 – Today, ProSomnus Sleep Technologies announced the addition of Edward T. […]
Read ArticleProSomnus® Sleep Technologies Announces Edward T. Sall, MD, DDS, MBA as Medical Director Read More »
by DeWitt C. Wilkerson, DMD In October 2017, the American Dental Association (ADA) released a policy statement addressing dentistry’s role in sleep-related breathing disorders.1 The policy encourages dental professionals to
Read CE ArticleA Checklist for Evaluation of Potential Airway and Breathing Disorders Read More »
What therapeutic options does a sleep dentist have when Oral Appliance (OA) monotherapy fails? Since most dental sleep patients choose OAT (oral appliance therapy) because they have already rejected CPAP
Read ArticleCombination Therapy by Ronald S. Prehn, ThM, DDS Read More »
ADA policy statements have historically guided the evolution of our dental standards of care. The ADA House of Delegates adopted a policy on Sleep Disordered Breathing recently. Whenever the ADA
Read ArticleThere’s a buzz in larger corporations today about nurturing a culture of innovation, and in the dental sleep medicine field, it appears the idea of getting seriously innovative is being
Read ArticleMarketing From a Culture of Innovation by Chris Bez, opportunity engineer Read More »
by Neal Seltzer, DMD, FAGD, D.ABDSM, D.ACSDD, D.ASBD The time-tested, leading treatment options for Obstructive Sleep Apnea have been variations of surgery, Positive Air Pressure, Oral Appliance Therapy, or any
Read Article
Oral Appliance Therapy (OAT) for Obstructive Sleep Apnea (OSA) has been well established as a viable alternative to Continuous Positive Airway Pressure (CPAP) for lowering the Apnea Hypopnea Index (AHI).
Read Article
by Charles F. Collins, CEO – Airway Management For years, many members of the dental sleep medicine community have been predicting that this segment of dentistry is poised for exponential
Read ArticleSleep Medicine’s Seismic Shift to Dentists – Are You Ready? Read More »
The US and global impact of Obstructive Sleep Apnea (OSA) is staggering. An estimated 52 million Americans have sleep disordered breathing, with 1 in 5 having mild apnea, and 1
Read Article
French manufacturer BlueSom first launched BluePro® in Europe in 2014 and then received FDA clearance in December 2016 for the treatment of snoring and mild to moderate OSA. After launching
Read ArticleBluePro® Temporary Appliance: Clinical Profile Read More »
